KAILENN TSAO, MD
Ophthalmology Physician in WINCHESTER, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
KAILENN TSAO, MD reported a CMS MIPS final score of 96.1983/100 — above the 83.1 national average — and filed 526 Medicare Part D claims in 2023.
- 96.1983/100
- MIPS score · +13 vs avg
- 526
- Part D claims, 2023
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
KAILENN TSAO, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
96 Top 17% higher than 83% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
KAILENN TSAO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about KAILENN TSAO, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Massachusetts
How Ophthalmology Physician compares to other specialties among Massachusetts providers
Ophthalmology Physician share within Massachusetts
Ophthalmology Physician is one of the more visible NUCC categories in Massachusetts
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
KAILENN TSAO, MD's 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 96.1983/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) — 96.1983/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Ophthalmology Physician US NPIs
96.1983/100 MIPS final score — 13.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Ophthalmology Physician. Quality dim: 92.3965.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
KAILENN TSAO, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 955 MAIN ST, WINCHESTER, MA, 01890, with a listed phone of (781) 729-7401. NPI 1912961335 was issued on 04/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TSAO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 526 prescription claims written by this provider, covering 137 Medicare beneficiaries and totaling roughly $51K in drug spend, split 22% brand-name and 78% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.1983/100 for the 2023 performance year (Quality 92.3965), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1912961335 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/13/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm KAILENN TSAO, MD's current license status, disciplinary history, and board certifications with the Massachusetts Board of Registration in Medicine in Massachusetts before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context — Massachusetts BORIM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to KAILENN TSAO, MD. To verify KAILENN TSAO, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 526 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 923
- Total Day Supply
- 24,728
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $31K
- Generic Drug Cost
- $20K
Patient Demographics
- Average Patient Age
- 78.4 years
- Avg HCC Risk Score
- 1.00
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 0, 65-74: 35, 75-84: 78, 85+: 24
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What KAILENN TSAO, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
135 claims
- Ketorolac Trometha…
Ketorolac Tromethamine
63 claims
- Erythromycin
Erythromycin
62 claims
- Tobramycin-Dexamet… 51
Tobramycin-Dexamethasone
51 claims
- Timolol Maleate 40
Timolol Maleate
40 claims
- Prednisolone Acetate 27
Prednisolone Acetate
27 claims
- Dorzolamide Hcl 20
Dorzolamide Hcl
20 claims
- Combigan 18
Combigan
18 claims
| Drug | Claims |
|---|---|
| Latanoprost | 135 |
| Ketorolac Tromethamine | 63 |
| Erythromycin Erythromycin Base | 62 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 51 |
| Timolol Maleate | 40 |
| Prednisolone Acetate | 27 |
| Dorzolamide Hcl | 20 |
| Combigan Brimonidine Tartrate/Timolol | 18 |
| Brimonidine Tartrate | 17 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How KAILENN TSAO, MD fits within the Ophthalmology Physician landscape nationally.
KAILENN TSAO, MD's 526 claims are below the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Massachusetts
Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as TSAO.
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Massachusetts
Frequently Asked Questions
What is KAILENN TSAO, MD's specialty? ▼
How much does KAILENN TSAO, MD prescribe under Medicare Part D? ▼
What is KAILENN TSAO, MD's Medicare quality score? ▼
Where is KAILENN TSAO, MD located? ▼
What is KAILENN TSAO, MD's NPI number? ▼
Does KAILENN TSAO, MD prescribe more brand-name or generic drugs? ▼
How many Ophthalmology Physician providers are there in the US? ▼
What drugs does KAILENN TSAO, MD prescribe most often? ▼
Does KAILENN TSAO, MD accept Medicare? ▼
How can I verify KAILENN TSAO, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology